enleofen.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Home -
Description Transforming the treatment of fibro-inflammatory Enleofen was founded as a spin-out from NHCS, SingHealth and Duke-NUS Medical School focused on developing new anti-fibrotic
Keywords N/A
Server Information
WebSite enleofen faviconenleofen.com
Host IP 104.155.212.239
Location United States
Related Websites
Site Rank
More to Explore
enleofen.com Valuation
US$1,772,496
Last updated: 2023-05-17 20:25:37

enleofen.com has Semrush global rank of 5,971,413. enleofen.com has an estimated worth of US$ 1,772,496, based on its estimated Ads revenue. enleofen.com receives approximately 204,519 unique visitors each day. Its web server is located in United States, with IP address 104.155.212.239. According to SiteAdvisor, enleofen.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,772,496
Daily Ads Revenue US$1,637
Monthly Ads Revenue US$49,085
Yearly Ads Revenue US$589,014
Daily Unique Visitors 13,635
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
enleofen.com. A 3600 IP: 104.155.212.239
enleofen.com. NS 21600 NS Record: ns1.dnsowl.com.
enleofen.com. NS 21600 NS Record: ns2.dnsowl.com.
enleofen.com. NS 21600 NS Record: ns3.dnsowl.com.
enleofen.com. MX 86400 MX Record: 5 alt2.aspmx.l.google.com.
enleofen.com. MX 86400 MX Record: 10 alt3.aspmx.l.google.com.
enleofen.com. MX 86400 MX Record: 10 alt4.aspmx.l.google.com.
enleofen.com. MX 86400 MX Record: 1 aspmx.l.google.com.
enleofen.com. MX 86400 MX Record: 5 alt1.aspmx.l.google.com.
HtmlToTextCheckTime:2023-05-17 20:25:37
× Home Our Focus Our Strategy News Contact Us × What are you looking for? Transforming the treatment of fibro-inflammatory diseases Developer of first-in-class therapeutics targeting the IL-11 pathway Our Focus IL-11 signalling is a fundamentally important driver of fibrogenesis, organ dysfunction and inflammation across human fibrotic diseases. Enleofen develops innovative, safe and highly effective therapeutics that address today’s biggest healthcare challenges. Our Strategy Patient-based discovery platform Therapeutic development based on relevant biology Efficacy across disease models and extensive safety studies Strong human genetic data supporting drug safety Extensive patent portfolio Read More Latest News Contact Us Copyright: Enleofen Bio Pte
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 18 Apr 2022 09:12:31 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: http://www.enleofen.com/

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 18 Apr 2022 09:12:32 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://www.enleofen.com/

HTTP/2 200 
server: nginx
date: Mon, 18 Apr 2022 09:12:33 GMT
content-type: text/html; charset=UTF-8
content-length: 135730
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes
enleofen.com Whois Information
Domain Name: ENLEOFEN.COM
Registry Domain ID: 2090685289_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.namesilo.com
Registrar URL: http://www.namesilo.com
Updated Date: 2019-12-04T09:28:32Z
Creation Date: 2017-01-17T01:59:42Z
Registry Expiry Date: 2023-01-17T01:59:42Z
Registrar: NameSilo, LLC
Registrar IANA ID: 1479
Registrar Abuse Contact Email: abuse@namesilo.com
Registrar Abuse Contact Phone: +1.4805240066
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.DNSOWL.COM
Name Server: NS2.DNSOWL.COM
Name Server: NS3.DNSOWL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-04-18T09:33:58Z <<<